Article
Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations.
Diabetes care - 1 Jan 2008
Equitani Francesco, Fernandez-Real Josè Manuel, Menichella Giacomo, Koch Maurizio, Calvani Menotti, Nobili Valerio, Mingrone Geltrude, Manco Melania
Abstract excerpt
OBJECTIVE: To clarify the pathogenesis of diabetes associated with mutations of the hemochromatosis (HFE) gene, 17 carriers, 9 normal glucose tolerant (NGT) and 8 diabetic, were evaluated in an interventional trial. RESEARCH DESIGN AND METHODS: At enrollment and after a 2-year bloodletting period, euglycemic-hyperinsulinemic clamp, oral glucose tolerance test (OGTT), liver histology (nonalcoholic fatty liver...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
